February | 2017 | Profusa, Inc.

In the European Union, the Lumee™ Oxygen Platform is CE Marked. In the United States, the Lumee Oxygen Platform is an Investigational Device Limited by Federal Law to Investigational Use.

News & Events

For media inquiries, please contact [email protected].

Profusa, Inc. and North Carolina State University’s ASSIST Center Awarded $1.5M NIH Grant to Co-Develop Ultrathin, Wearable, Wireless, Oxygen Monitor for Patients with Peripheral Artery Disease

February 6, 2017

SOUTH SAN FRANCISCO, Calif. and RALEIGH, N.C., February 6, 2017 — Profusa, Inc. and North Carolina State University’s ASSIST Center today announced their collaboration to develop an ultrathin flexible-patch reader worn on the skin for ...